» Articles » PMID: 35112034

Electrophysiology of Guillain-Barré Syndrome in Bangladesh: A Prospective Study of 312 Patients

Overview
Publisher Elsevier
Specialty Neurology
Date 2022 Feb 3
PMID 35112034
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe the electrophysiological features in relation to clinical and serological findings of Guillain-Barré syndrome (GBS) in the national neuroscience hospital in Bangladesh. This is one of the few studies that investigated GBS patients using standardized electrophysiology in low-income countries.

Methods: In a prospective and observational study, we investigated 312 GBS patients by standardized clinical, serological and electrophysiological methods. Unilateral motor and sensory nerve conduction studies (NCS) were performed within two weeks of onset of weakness. Follow up NCS were performed in 189 patients and classified according to eight sets of established GBS criteria. Serology included assessment of anti-GM1 antibodies and anti-campylobacter jejuni lipo-oligosaccharide (LOS) antibodies.

Results: Depending on the criteria used, 44-59% patients had axonal GBS with anti-GM1 antibodies being present in 55-58% and 9-42% patients had demyelinating GBS with anti-GM1 antibodies being present in 7-35%. Conduction block (CB) with demyelinative slowing in the same nerve segment was found in 24% (74/312) patients, and CB without demyelinative slowing in the same nerve segment was found in 18% (56/312) patients, of whom anti-GM1 antibodies were found in 27% and 57% patients respectively. Follow-up NCS showed a change in GBS classification in 11-26% of patients, mainly from demyelinating to axonal GBS.

Conclusions: The predominant subtype of GBS in Bangladesh is axonal but demyelinating GBS also occurs with classification being strongly dependent on the applied criteria.

Significance: The present study demonstrates the importance of reaching international agreement on GBS criteria that should be based on the best evidence.

Citing Articles

Pain determinants and quality of life in Guillain-Barre syndrome: a prospective cohort study.

Papri N, Mohammed A, Rahman M, Hasan I, Azam R, Saha T BMJ Neurol Open. 2024; 6(2):e000925.

PMID: 39687605 PMC: 11647308. DOI: 10.1136/bmjno-2024-000925.


Expression of recombinant Omp18 and MOMP of and the determination of their suitability as antigens for serological diagnosis of campylobacteriosis in animals.

Borovikov S, Tursunov K, Syzdykova A, Begenova A, Zhakhina A Vet World. 2023; 16(1):222-228.

PMID: 36855354 PMC: 9967712. DOI: 10.14202/vetworld.2023.222-228.


Triggers of Guillain-Barré Syndrome: Predominates.

Finsterer J Int J Mol Sci. 2022; 23(22).

PMID: 36430700 PMC: 9696744. DOI: 10.3390/ijms232214222.

References
1.
van Asseldonk J, van den Berg L, Kalmijn S, Wokke J, Franssen H . Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy. Brain. 2005; 128(Pt 4):880-91. DOI: 10.1093/brain/awh375. View

2.
Sleutjes B, Wijngaarde C, Wadman R, Otto L, Asselman F, Cuppen I . Assessment of motor unit loss in patients with spinal muscular atrophy. Clin Neurophysiol. 2020; 131(6):1280-1286. DOI: 10.1016/j.clinph.2020.01.018. View

3.
Van den Bergh P, Pieret F . Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2004; 29(4):565-74. DOI: 10.1002/mus.20022. View

4.
Uncini A, Ippoliti L, Shahrizaila N, Sekiguchi Y, Kuwabara S . Optimizing the electrodiagnostic accuracy in Guillain-Barré syndrome subtypes: Criteria sets and sparse linear discriminant analysis. Clin Neurophysiol. 2017; 128(7):1176-1183. DOI: 10.1016/j.clinph.2017.03.048. View

5.
Uncini A, Kuwabara S . Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatry. 2015; 86(11):1186-95. DOI: 10.1136/jnnp-2014-310097. View